Remove 2011 Remove Biotechnology Remove Planning Remove Team
article thumbnail

India Remakes Global Innovation

Harvard Business Review

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market.

article thumbnail

Get Your Passion Project Moving Without Quitting Your Day Job

Harvard Business Review

Your timeline, she says, should include clearly defined savings targets for each month or quarter and — if necessary — a plan for raising money from investors. “But if you’ve planned your transition well, you’re not taking a heedless risk.” ” Further Reading. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. In 2011, he commissioned a report that called for an “innovation policy” rather than an “industrial policy.” So far, the program has exceeded the expectations of the initial plan. The Era of Big Science.

article thumbnail

The Industries Plagued by the Most Uncertainty

Harvard Business Review

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.